CDK12 and ovarian cancer: Our approach confirmed the presence of these driver mutations in four genes (CDK12, LATS1, RB1, and TP53) and seven genomic regions reported by PCAWG in the ovarian cancer dataset (Supplementary Data 9), validating the use of our functional annotations and chromatin states.